Search

everythinglearnresearchcommunity

for

Search:↓

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Elagolix did not effectively treat polycystic ovary syndrome.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Some gonadal hormone drugs can block filovirus entry into cells.

A patient with complete hair loss regrew all her hair using tofacitinib.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Two women lost hair after mesotherapy for hair loss, with one having permanent and the other temporary hair loss.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

CS12192 effectively treats alopecia areata with better safety than current options.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Fractional CO2 laser is more effective and safer than steroid injections for treating alopecia areata.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.